Cargando…
Development and validation of an interstitial lung disease exposure questionnaire for sub-Saharan Africa
BACKGROUND: American Thoracic Society/European Respiratory Society guidelines recommend context-specific exposure assessments to diagnose interstitial lung disease (ILD). In sub-Saharan Africa, ILD diagnoses are rare, and locally validated ILD exposure questionnaires are not used. METHODS: A physici...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792102/ https://www.ncbi.nlm.nih.gov/pubmed/36578631 http://dx.doi.org/10.1183/23120541.00205-2022 |
_version_ | 1784859561198354432 |
---|---|
author | Jackson, Peter Padalkar, Roma Katagira, Winceslaus Mortimer, Kevin Rykiel, Natalie A. Robertson, Nicole M. Pollard, Suzanne L. Alupo, Patricia Checkley, William Kirenga, Bruce Siddharthan, Trishul |
author_facet | Jackson, Peter Padalkar, Roma Katagira, Winceslaus Mortimer, Kevin Rykiel, Natalie A. Robertson, Nicole M. Pollard, Suzanne L. Alupo, Patricia Checkley, William Kirenga, Bruce Siddharthan, Trishul |
author_sort | Jackson, Peter |
collection | PubMed |
description | BACKGROUND: American Thoracic Society/European Respiratory Society guidelines recommend context-specific exposure assessments to diagnose interstitial lung disease (ILD). In sub-Saharan Africa, ILD diagnoses are rare, and locally validated ILD exposure questionnaires are not used. METHODS: A physician-administered ILD exposure questionnaire was developed using a four-step mixed-methods modified Delphi approach. First, ILD questionnaires from high-income countries and data from Pneumotox were reviewed, compiled and face-validated. Second, a local pilot group of ILD experts ranked item relevance using a Likert scale and suggested additions. Third, the questionnaire format and pilot rankings were addressed in a focus group discussion that was analysed using grounded theory. Finally, following focus group discussion modifications, the resulting items (with three duplicate item groups for evaluation of internal consistency) were ranked for importance by members of the Pan-African Thoracic Society (PATS). RESULTS: Face validation resulted in 82 items in four categories: “Smoking and Drugs”, “Environmental Exposures”, “Occupations” and “Medications”. Pilot group (n=10) ranking revealed 27 outliers and 30 novel suggestions. Focus group (n=12) discussion resulted in 10 item deletions, 14 additions and 22 re-wordings; themes included desire for extensive questionnaires and stigma sensitivity. Final validation involved 58 PATS members (mean±sd age 46±10.6 years, 76% male, from 17 countries) ranking 84 items derived from previous steps and three duplicate question groups. The questionnaire was internally consistent (Cronbach's α >0.80) and ultimately included 73 items. CONCLUSION: This mixed-methods study included experts from 17 countries in sub-Saharan Africa and successfully developed a 73-item ILD exposure questionnaire for sub-Saharan Africa. African pulmonary experts valued region-specific additions and ranked several items from existing ILD questionnaires as unimportant. |
format | Online Article Text |
id | pubmed-9792102 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-97921022022-12-27 Development and validation of an interstitial lung disease exposure questionnaire for sub-Saharan Africa Jackson, Peter Padalkar, Roma Katagira, Winceslaus Mortimer, Kevin Rykiel, Natalie A. Robertson, Nicole M. Pollard, Suzanne L. Alupo, Patricia Checkley, William Kirenga, Bruce Siddharthan, Trishul ERJ Open Res Original Research Articles BACKGROUND: American Thoracic Society/European Respiratory Society guidelines recommend context-specific exposure assessments to diagnose interstitial lung disease (ILD). In sub-Saharan Africa, ILD diagnoses are rare, and locally validated ILD exposure questionnaires are not used. METHODS: A physician-administered ILD exposure questionnaire was developed using a four-step mixed-methods modified Delphi approach. First, ILD questionnaires from high-income countries and data from Pneumotox were reviewed, compiled and face-validated. Second, a local pilot group of ILD experts ranked item relevance using a Likert scale and suggested additions. Third, the questionnaire format and pilot rankings were addressed in a focus group discussion that was analysed using grounded theory. Finally, following focus group discussion modifications, the resulting items (with three duplicate item groups for evaluation of internal consistency) were ranked for importance by members of the Pan-African Thoracic Society (PATS). RESULTS: Face validation resulted in 82 items in four categories: “Smoking and Drugs”, “Environmental Exposures”, “Occupations” and “Medications”. Pilot group (n=10) ranking revealed 27 outliers and 30 novel suggestions. Focus group (n=12) discussion resulted in 10 item deletions, 14 additions and 22 re-wordings; themes included desire for extensive questionnaires and stigma sensitivity. Final validation involved 58 PATS members (mean±sd age 46±10.6 years, 76% male, from 17 countries) ranking 84 items derived from previous steps and three duplicate question groups. The questionnaire was internally consistent (Cronbach's α >0.80) and ultimately included 73 items. CONCLUSION: This mixed-methods study included experts from 17 countries in sub-Saharan Africa and successfully developed a 73-item ILD exposure questionnaire for sub-Saharan Africa. African pulmonary experts valued region-specific additions and ranked several items from existing ILD questionnaires as unimportant. European Respiratory Society 2022-12-19 /pmc/articles/PMC9792102/ /pubmed/36578631 http://dx.doi.org/10.1183/23120541.00205-2022 Text en Copyright ©The authors 2022 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
spellingShingle | Original Research Articles Jackson, Peter Padalkar, Roma Katagira, Winceslaus Mortimer, Kevin Rykiel, Natalie A. Robertson, Nicole M. Pollard, Suzanne L. Alupo, Patricia Checkley, William Kirenga, Bruce Siddharthan, Trishul Development and validation of an interstitial lung disease exposure questionnaire for sub-Saharan Africa |
title | Development and validation of an interstitial lung disease exposure questionnaire for sub-Saharan Africa |
title_full | Development and validation of an interstitial lung disease exposure questionnaire for sub-Saharan Africa |
title_fullStr | Development and validation of an interstitial lung disease exposure questionnaire for sub-Saharan Africa |
title_full_unstemmed | Development and validation of an interstitial lung disease exposure questionnaire for sub-Saharan Africa |
title_short | Development and validation of an interstitial lung disease exposure questionnaire for sub-Saharan Africa |
title_sort | development and validation of an interstitial lung disease exposure questionnaire for sub-saharan africa |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792102/ https://www.ncbi.nlm.nih.gov/pubmed/36578631 http://dx.doi.org/10.1183/23120541.00205-2022 |
work_keys_str_mv | AT jacksonpeter developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica AT padalkarroma developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica AT katagirawinceslaus developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica AT mortimerkevin developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica AT rykielnataliea developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica AT robertsonnicolem developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica AT pollardsuzannel developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica AT alupopatricia developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica AT checkleywilliam developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica AT kirengabruce developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica AT siddharthantrishul developmentandvalidationofaninterstitiallungdiseaseexposurequestionnaireforsubsaharanafrica |